US Food and Drug Administration today (November 17) announced that it will be certified to pass & nbsp; VR & NBSP; to treat chronic back pain. This kind of treatment named EASEVRX officially added the list of digital therapies launched in the past few years.
EaseVRX includes a VR headset display and a device that enhances user breathing sound to help users' breathing exercises. It is intended to help people identify and understand various thinking patterns and emotions by cognitive behavioral therapy.
The FDA resolves the pain problem by relaxing, dispersing, and improving the body signals in a statement.
The FDA approved Easevrx according to an 8-week research data, which studied 179 patients with low back pain in six months or longer. Halfway uses an Easevrx program, half participating in another two-dimensional virtual reality that does not use cognitive behavioral therapy methods.
About two-thirds of the participants using Easevrx said their pain has been reduced by more than 30%, while only 41% of the participants in the control group have similar alleviation.
After studying the people of the Easevrx group, the pain of alleviating continued for up to three months, and the control group did not.
Christopher Loftus, director of the FDA Nerve and Physical Medical Equipment Office, said in a statement that the VR system may be an alternative choice for the treatment of back pain.
Studies have shown that psychotherapy can effectively treat some people's chronic pain, supporters emphasize that these ingredients do not mean that pain is not so true.
despite this,Pain's cognitive behavioral therapy is sometimes controversial, and the efforts of integrating it into standard care have led to people's concerns, that is, it will be used as an excuse to stop taking the desired drug.
Easevrx is developed by AppliedvR, which is also tested as a method for treating fiber myoglia, burning pain or childbirth.
The FDA was also approved by the FDA before this, and the treatment game called Endeavorrx was used to treat children with 8 to 12 years old.